Clinical Trial Update: Ultra-early Tranexamic Acid After Subarachnoid Hemorrhage. [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating ultra-early tranexamic acid after subarachnoid hemorrhage has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subarachnoid Hemorrhage

Drugs mentioned

• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Subarachnoid Hemorrhage | Phase 2, Phase 3 | Status: COMPLETED